Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CYP2C19 genetic polymorphism in Thai, Burmese and Karen populations.

Drug metabolism and pharmacokinetics - 1 Aug 2006

Tassaneeyakul Wichittra, Mahatthanatrakul Werawath, Niwatananun Kanokporn, Na-Bangchang Kesara, Tawalee Arporn, Krikreangsak Nathawut, Cykleng Utaiwan, Tassaneeyakul Wongwiwat

Abstract excerpt

The genetic polymorphism of CYP2C19 was examined in three Southeast Asian populations. This study was conducted in 774 Thais, 127 Burmeses and 131 Karens. Genomic DNA was extracted from leucocytes and analyzed by the PCR-RFLP technique. Genotype analysis revealed that the allele frequencies of CYP2C19*1, CYP2C19*2 and CYP2C19*3 in the Thais were 0.68, 0.29 and 0.03, respectively, and those of the Burmese...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aryl Hydrocarbon Hydroxylases
Share to Asian People

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytochrome P-450 CYP2C19

Share to Ethnicity

Share to Gene Frequency

Share to Mixed Function Oxygenases

Share to Myanmar

Share to Thailand

Source

Identifiers

PMID: 16946555
DOI: 10.2133/dmpk.21.286

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CYP2C19 genetic polymorphism in Thai, Burmese and Karen populations.PMID 16946555Read ↗

Allele frequencies of single nucleotide polymorphisms of clinically important drug-metabolizing enzymes CYP2C9, CYP2C19, and CYP3A4 in a Thai population.Semantic proximity Read ↗

Analysis of the CYP2C19 polymorphism in a North-eastern Thai population.Semantic proximity Read ↗

Allele and genotype frequency of CYP2C19 in a Tamilian population.Semantic proximity Read ↗

Pharmacogenetic relevant polymorphisms of CYP2C9, CYP2C19, CYP2D6, and CYP3A5 in Bhutanese population.Semantic proximity Read ↗

Allele and genotype frequency of CYP2C9 in Tamilnadu population.Semantic proximity Read ↗

CYP2C19 genetic polymorphism in Saudi Arabians.Semantic proximity Read ↗

Ethnic and geographical distributions of CYP2C19 alleles in the populations of Southeast Asia.Semantic proximity Read ↗

Estimation of polymorphisms in the drug-metabolizing enzyme, cytochrome P450 2C19 gene in six major ethnicities of Pakistan.Semantic proximity Read ↗

Genetic polymorphisms of drug-metabolizing phase I enzymes CYP3A4, CYP2C9, CYP2C19 and CYP2D6 in Han, Uighur, Hui and Mongolian Chinese populations.Semantic proximity Read ↗

Prevalence of the CYP2C19*2 (681 G>A), *3 (636 G>A) and *17 (‑806 C>T) alleles among an Iranian population of different ethnicities.Semantic proximity Read ↗

High and variable frequencies of CYP2C19 mutationsSemantic proximity Read ↗

Comparison of genetic variation in drug ADME-related genes in Thais with Caucasian, African and Asian HapMap populations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.